8+ hour, 15+ min ago  (478+ words) PR Newswire'May. 30, 2026 21: 01 At his first graduation as Dean, Patrick Tan presides over a record class of 135 graduates, with Guest of Honour Mdm Rahayu Mahzam and keynote speaker Dr Robert Califf SINGAPORE, May 30, 2026 /PRNewswire/ -- From engineers and business graduates to literature…...

1+ mon, 1+ week ago  (201+ words) An established forum for evidence-based clinical discussion, interdisciplinary dialogue, and patient considerations Event is expanded to two days, live and virtual on June 11-12, 2026, at the Ma RS Discovery District, Toronto In addition to live sessions, this event will be recorded…...

3+ mon, 1+ week ago  (75+ words) Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026 Lawmakers call for Taiwan office name change Taiwan congratulates Takaichi on re-election as Japan prime minister Taiwan's house…...

4+ mon, 1+ day ago  (159+ words) PR Newswire'Jan. 29, 2026 22: 00 SEOUL, South Korea, Jan. 29, 2026 /PRNewswire/ -- NEXTBIOMEDICAL CO. , LTD. (KOSDAQ: 389650), an innovative medical device company based in South Korea, announced today that Nexsphere-F, the company's novel fast resorbable microsphere for musculoskeletal pain embolization has received approval from Health Canada....

5+ mon, 3+ week ago  (344+ words) Hope Stride integrates AI and exoskeleton to help patients get back on their feet "Dec. 4, 2025 17: 11 TAIPEI (Taiwan News) " A Taiwanese research team has developed the world's first AI-powered gait-rehabilitation machine that allows patients to walk using only their thoughts, CNA…...

7+ mon, 1+ day ago  (194+ words) Paul Emery, M. D. , professor of rheumatology at the University of Leeds and "Leeds Biomedical Research Centre, U. K. , presented data that show: The presentation is available for download on the Anaptys website here. About the RENOIR Trial About Rosnilimab Rosnilimab is a novel…...

10+ mon, 1+ week ago  (810+ words) THE WOODLANDS, Texas, July 18, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that data from a study of patients describing the impact of diabetic peripheral. .. Lexicon to Present Patient-reported Data on Diabetic Peripheral Neuropathic Pain (DPNP) at the 7th Annual…...

10+ mon, 2+ week ago  (276+ words) This randomized, double-masked, placebo-controlled, Phase 2 Proof-of-Concept trial of urcosimod to treat NCP was conducted at a single trial site at Tufts Medical Center in Boston, MA, with Pedram Hamrah, M. D. , a leading expert in NCP, as Principal Investigator. Top Line Data…...

9+ mon, 2+ week ago  (364+ words) Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years Fibromyalgia is a chronic pain condition that affects more than 10 million adults in the U. S. who are mostly women Two Pivotal Phase 3 studies demonstrated Tonmya significantly reduced…...

11+ mon, 4+ day ago  (133+ words) New Study Provides Insight into the Bioavailability of Medical Cannabis Formulations for Therapeutic Treatment This pilot study shows that oral administration of Tilray THC: CBD extract formulation achieved higher THC and CBD concentrations within a shorter timeframe compared to the…...